These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28154935)

  • 41. Two elderly cases of familial mediterranean fever with rheumatoid arthritis.
    Matsuoka N; Iwanaga J; Ichinose Y; Fujiyama K; Tsuboi M; Kawakami A; Migita K
    Int J Rheum Dis; 2018 Oct; 21(10):1873-1877. PubMed ID: 24661635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations.
    Moradian MM; Sarkisian T; Ajrapetyan H; Avanesian N
    J Hum Genet; 2010 Jun; 55(6):389-93. PubMed ID: 20485448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease.
    Stoffels M; Szperl A; Simon A; Netea MG; Plantinga TS; van Deuren M; Kamphuis S; Lachmann HJ; Cuppen E; Kloosterman WP; Frenkel J; van Diemen CC; Wijmenga C; van Gijn M; van der Meer JW
    Ann Rheum Dis; 2014 Feb; 73(2):455-61. PubMed ID: 23505238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of Tel-Hashomer, Livneh, pediatric and new Eurofever/PRINTO classification criteria for familial Mediterranean fever in a referral center.
    Tanatar A; Sönmez HE; Karadağ ŞG; Çakmak F; Çakan M; Demir F; Sözeri B; Ayaz NA
    Rheumatol Int; 2020 Jan; 40(1):21-27. PubMed ID: 31646357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive analysis of a large-scale screen for MEFV gene mutations: do they truly provide a "heterozygote advantage" in Turkey?
    Berdeli A; Mir S; Nalbantoglu S; Kutukculer N; Sozeri B; Kabasakal Y; Cam S; Solak M
    Genet Test Mol Biomarkers; 2011; 15(7-8):475-82. PubMed ID: 21413889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The Cutting-edge of Medicine: Hereditary autoinflammatory diseases: diagnosis and management].
    Migita K; Kawakami A; Eguchi K
    Nihon Naika Gakkai Zasshi; 2014 Oct; 103(10):2594-602. PubMed ID: 27514211
    [No Abstract]   [Full Text] [Related]  

  • 47. Apoptosis-associated speck-like protein containing a CARD (ASC) expression profiles in familial Mediterranean fever (FMF) patients with different MEFV mutation patterns.
    Nalbantoglu S; Tanyolac B; Berdeli A
    Scand J Rheumatol; 2013; 42(2):159-62. PubMed ID: 22934972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutational Spectrum of the MEFV Gene in AA Amyloidosis Associated With Familial Mediterranean Fever.
    Nursal AF; Tekcan A; Kaya SU; Turkmen E; Yigit S
    Iran J Kidney Dis; 2016 May; 10(3):107-12. PubMed ID: 27225717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study.
    Caglayan AO; Demiryilmaz F; Ozyazgan I; Gumus H
    Nephrol Dial Transplant; 2010 Aug; 25(8):2520-3. PubMed ID: 19934083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experimental models in Familial Mediterranean Fever (FMF): Insights into pathophysiology and therapeutic strategies.
    Mezher N; Mroweh O; Karam L; Ibrahim JN; Kobeissy PH
    Exp Mol Pathol; 2024 Feb; 135():104883. PubMed ID: 38266955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients.
    Magnotti F; Lefeuvre L; Benezech S; Malsot T; Waeckel L; Martin A; Kerever S; Chirita D; Desjonqueres M; Duquesne A; Gerfaud-Valentin M; Laurent A; Sève P; Popoff MR; Walzer T; Belot A; Jamilloux Y; Henry T
    EMBO Mol Med; 2019 Nov; 11(11):e10547. PubMed ID: 31589380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Expanding Spectrum of Autoinflammatory Diseases.
    Migita K; Fujita Y; Asano T; Sato S
    Intern Med; 2023; 62(1):43-50. PubMed ID: 36596474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The role of interleukin-1 and interleukin-1-receptor antagonist in development of familial mediterranean fever and other autoinflammatory diseases].
    Dzhidoian Z
    Georgian Med News; 2011 May; (194):53-6. PubMed ID: 21685523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MEFV mutations in familial Mediterranean fever: association of M694V homozygosity with arthritis.
    Olgun A; Akman S; Kurt I; Tuzun A; Kutluay T
    Rheumatol Int; 2005 May; 25(4):255-9. PubMed ID: 14727057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new MEFV gene mutation in an Iranian patient with familial Mediterranean fever.
    Farjadian S; Bonatti F; Soriano A; Reina M; Adorni A; Graziano C; Moghtaderi M; Percesepe A; Romeo G; Martorana D
    Reumatismo; 2019 Jul; 71(2):85-87. PubMed ID: 31309779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever.
    Giaglis S; Papadopoulos V; Kambas K; Doumas M; Tsironidou V; Rafail S; Kartalis G; Speletas M; Ritis K
    Clin Genet; 2007 May; 71(5):458-67. PubMed ID: 17489852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Familial Mediterranean Fever in Armenian population.
    Sarkisian T; Ajrapetian H; Beglarian A; Shahsuvarian G; Egiazarian A
    Georgian Med News; 2008 Mar; (156):105-11. PubMed ID: 18403822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Function and mechanism of the pyrin inflammasome.
    Heilig R; Broz P
    Eur J Immunol; 2018 Feb; 48(2):230-238. PubMed ID: 29148036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease (FMF-BD).
    Livneh A; Aksentijevich I; Langevitz P; Torosyan Y; G-Shoham N; Shinar Y; Pras E; Zaks N; Padeh S; Kastner DL; Pras M
    Eur J Hum Genet; 2001 Mar; 9(3):191-6. PubMed ID: 11313758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations in the B30.2 and the central helical scaffold domains of pyrin differentially affect inflammasome activation.
    Chirita D; Bronnec P; Magnotti F; Dalmon S; Martin A; Popoff M; Gerfaud-Valentin M; Sève P; Belot A; Contis A; Duquesne A; Nocturne G; Lemelle I; Georgin-Lavialle S; Boursier G; Touitou I; Jamilloux Y; Henry T
    Cell Death Dis; 2023 Mar; 14(3):213. PubMed ID: 36966139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.